BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27014602)

  • 1. How does a real-world child psychiatric clinic diagnose and treat attention deficit hyperactivity disorder?
    Yuki K; Bhagia J; Mrazek D; Jensen PS
    World J Psychiatry; 2016 Mar; 6(1):118-27. PubMed ID: 27014602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial.
    Myers K; Vander Stoep A; Zhou C; McCarty CA; Katon W
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):263-74. PubMed ID: 25791143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
    Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.
    Leslie LK; Weckerly J; Plemmons D; Landsverk J; Eastman S
    Pediatrics; 2004 Jul; 114(1):129-40. PubMed ID: 15231919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder.
    Garg J; Arun P; Chavan BS
    Int J Appl Basic Med Res; 2015; 5(2):114-8. PubMed ID: 26097819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG; Sener S
    Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An open trial on effectiveness of parent training in children with comorbid attention deficit hyperactivity disorder and oppositional defiant disorder].
    Liu J; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):310-4. PubMed ID: 17572790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit-hyperactivity disorder with and without oppositional defiant disorder in 3- to 7-year-old children.
    Kadesjö C; Hägglöf B; Kadesjö B; Gillberg C
    Dev Med Child Neurol; 2003 Oct; 45(10):693-9. PubMed ID: 14515941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between preschool children with ODD, ADHD, and ODD+ADHD symptoms.
    Gadow KD; Nolan EE
    J Child Psychol Psychiatry; 2002 Feb; 43(2):191-201. PubMed ID: 11902598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parent and teacher rating scales in the evaluation of attention-deficit hyperactivity disorder: contribution to diagnosis and differential diagnosis in clinically referred children.
    Tripp G; Schaughency EA; Clarke B
    J Dev Behav Pediatr; 2006 Jun; 27(3):209-18. PubMed ID: 16775518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Ferritin on Short-Term Treatment Response in Attention Deficit Hyperactivity Disorder.
    Oner P; Oner O; Cop E; Munir KM
    Klinik Psikofarmakol Bulteni; 2012; 22(4):325-331. PubMed ID: 28804252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
    Kaplan S; Heiligenstein J; West S; Busner J; Harder D; Dittmann R; Casat C; Wernicke JF
    J Atten Disord; 2004 Oct; 8(2):45-52. PubMed ID: 15801334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helping Clinicians to Detect ODD in Children with ADHD in Clinical Settings.
    Tahillioğlu A; Dogan N; Ercan ES; Rohde LA
    Psychiatr Q; 2021 Jun; 92(2):821-832. PubMed ID: 33130959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROC Analyses of Relevant Conners 3-Short Forms, CBCL, and TRF Scales for Screening ADHD and ODD.
    Gomez R; Vance A; Watson S; Stavropoulos V
    Assessment; 2021 Jan; 28(1):73-85. PubMed ID: 31535569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P; Weizman A
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.